<DOC>
	<DOCNO>NCT00326248</DOCNO>
	<brief_summary>This study conduct see add GW679769 ( casopitant ) ZOFRAN significantly decrease number patient experience nausea vomit surgery .</brief_summary>
	<brief_title>Casopitant ( Oral ) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<mesh_term>Neurokinin-1 Receptor Antagonists</mesh_term>
	<criteria>Inclusion criterion : History PONV and/or motion sickness . Have smoke last 6 month . Having certain type abdominal , breast shoulder surgery . Exclusion criterion : Pregnant breastfeeding . Taking certain medication . Have certain preexist medical condition .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>postoperative nausea vomit PONV antiemetic NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride</keyword>
</DOC>